Patent application number | Description | Published |
20090053200 | Method for retarding unhealth manifestations brought by ageing of human beings - It is an object of the present invention to provide a solution for creating an effective method for retarding unhealthy manifestations brought by ageing of human beings (in particular, but not limited to the reduction of sexual activity and fertility, climax, changes in glucose tolerance, reduction of cognitive and mnestic functions, reduction of stress resistance, development of organ and tissue sclerosis) without directly affecting the genetic apparatus of the ageing cells. | 02-26-2009 |
20100061971 | Method for Treating Human Diseases Associated With an Increased Deoxyribonucleic Acid Content in Extracellular Spaces of Tissues and a Medicinal Preparation for Carrying Out Said Method - The invention relates to medicine. The inventive method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and organs, consists in orally injecting a DNA ferment in a quantity of 20 000-500 000 Kunz units in a day per 1 kg of the body mass. The single dose of the inventive medicinal preparation for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and organs comprises 20 000-500 000 Kunz units of the DNAse ferment. The oral administration of the above-mentioned important doses of the preparation only allows the catalytically significant amount of DNAse to be absorbed into the systemic circulation in such a way that the dose-dependent treating effect thereof is exhibited. | 03-11-2010 |
20100150903 | Method for Treating Oncological Diseases - A method to treat solid tumors and other oncological diseases consists of parenterally injecting an agent which destroy's blood's extracellular DNA into the systemic blood circulation of a cancer patient to slow down malignant. The agent is embodied in the form of a DNAse enzyme and, more particularly, as a bovine pancreatic DNAse. Doses from 50,000-250,000,000 Kunz units/day are injected for 5-360 days. A binding agent or an agent that modifies the chemical composition of the blood extracellular DNA is additionally injected into the blood. This modifying agent is preferably an enzyme-ribonuclease. | 06-17-2010 |
20100303796 | Method for Treating Systemic DNA Mutation Disease - A treatment for systemic DNA mutation diseases accompanied with development of somatic mosaicism and elevation of blood extracellular DNA and, more particularly, to a treatment of diabetes mellitus and atherosclerosis. The inventive method consist from introducing a treatment agent into a circulating blood system of a patient diagnosed with systemic DNA mutation diseases when said treatment agent destroys extracellular DNA in said blood of said patient and wherein said treatment agent used to destroy said extracellular DNA is a DNASE enzyme: said agent might be administered in doses and regimens which sufficient to decrease number average molecular weight of circulating extracellular blood DNA in the blood of said patient; | 12-02-2010 |
20110189156 | Method for Treating Systemic Bacterial, Fungal and Protozoan Infection - A treatment for the diseases that are accompanied by quantitative and qualitative changes of blood extracellular DNA and, more particularly, to a treatment of systemic bacterial, fungal and protozoan infections. The inventive method consist from introducing a treatment agent into a circulating blood system of a patient diagnosed with systemic infection caused by bacteria, fungi or protozoa when said treatment agent destroys extracellular DNA in said blood of said patient and wherein said treatment agent used to destroy said extracellular DNA is a DNASE enzyme: said agent must be administered in doses and regimens which sufficient to decrease number average molecular weight of circulating extracellular blood DNA in the blood of said patient; such decrease of number average molecular weight might be measured by gel electrophoresis of extracellular blood DNA fraction from the blood of said patient. A DNASE enzyme may be further applied in a dose and regime that provide a DNA hydrolytic activity measured in blood plasma exceeding 1.5 Kunitz units per 1 ml of blood plasma for more than 12 hours within a period of 24 hours. | 08-04-2011 |
20130183283 | Method for Treating Systemic DNA Mutation Disease - The invention is directed to treatment of systemic DNA mutation diseases accompanied with development of somatic mosaicism and elevation of blood extracellular DNA. The inventive method comprises introducing a DNASE enzyme into the systemic blood circulation of a patient in doses and regimens which are sufficient to decrease average molecular weight of circulating extracellular blood DNA in the blood of said patient. | 07-18-2013 |
20130183284 | Method for Treating Systemic Bacterial, Fungal and Protozoan Infection - The invention is directed to a treatment of systemic bacterial, fungal and protozoan infections. The inventive method comprises introducing a DNase enzyme into a circulating blood system of a patient diagnosed with systemic infection caused by bacteria, fungi or protozoa, wherein said DNase enzyme destroys extracellular DNA in said blood of said patient, said DNase enzyme being administered in doses and regimens which are sufficient to decrease the average molecular weight of circulating extracellular blood DNA in the blood of said patient. | 07-18-2013 |
20130209443 | Method for Treating Oncological Diseases - A method to treat solid tumors and other oncological diseases consists of parenterally injecting an agent which destroy's blood's extracellular DNA into the systemic blood circulation of a cancer patient to slow down malignant. The agent is embodied in the form of a DNAse enzyme and, more particularly, as a bovine pancreatic DNAse. Doses from 50,000-250,000,000 Kunz units/day are injected for 5-360 days. A binding agent or an agent that modifies the chemical composition of the blood extracellular DNA is additionally injected into the blood. This modifying agent is preferably an enzyme-ribonuclease. | 08-15-2013 |
20130216516 | METHOD FOR TREATING DELAYED-TYPE HYPERSENSITIVITY - The invention is directed to treatment of delayed-type hypersensitivity reactions associated with changes of qualitative and/or quantitative composition of blood extracellular DNA and treatment of systemic DNA mutation diseases accompanied with development of somatic mosaicism and elevation of blood extracellular DNA. The inventive method comprises introducing a DNASE enzyme into the systemic blood circulation of a patient in doses and regimens which are sufficient to decrease average molecular weight of circulating extracellular blood DNA in the blood of said patient. | 08-22-2013 |
20150110769 | METHOD FOR RETARDING UNHEALTHY MANIFESTATIONS BROUGHT BY AGEING OF HUMAN BEINGS - The present invention provides a method for retarding unhealthy manifestations brought by ageing of human beings (in particular, but not limited to the reduction of sexual activity and fertility, climax, changes in glucose tolerance, reduction of cognitive and mnestic functions, reduction of stress resistance, development of organ and tissue sclerosis). According to the invention this task is solved by administration into the blood circulation of an agent which inactivates extracellular blood plasma DNA e.g. a DNase enzyme. | 04-23-2015 |
Patent application number | Description | Published |
20080300130 | Catalyst For Improving The Adiabatic Steam Reforming Of Natural Gas - A catalyst for adiabatically prereforming a feedstock wherein the catalyst comprises 1 to 20 wt. % nickel and 0.4 to 5 wt. % potassium on a calcium aluminate support. The overall catalyst porosity is greater than 40% with greater than 70% of the overall catalyst porosity contributed by pores having pore diameters of at least 500 Å, and having a median pore diameter greater than 2600 Å, and having a nitrogen BET area less than 6.5 m | 12-04-2008 |
20090094894 | Method and Apparatus for Producing a Hydrogen-Containing Gas - A process and apparatus for producing a hydrogen-containing gas in a reformer where a furnace, which is independent of the reformer, heats the effluent from a prereformer prior to reacting the prereformer effluent in the reformer. The prereformer effluent may be heated in a heat exchange tube in the furnace where the heat exchange tube is positioned in the furnace to preclude direct radiation from any flames in the furnace thereby preventing local overheating of the heat exchange tube and preventing carbon formation in the heat exchange tube. Fuel and oxidant gas may be introduced into the furnace with significant excess oxidant gas, having a stoichiometric ratio of 1.8 to 2.8 for controlling the temperature of the heat exchange tube. | 04-16-2009 |
20090230359 | Steam-Hydrocarbon Reforming Method with Limited Steam Export - A method for generating hydrogen and/or syngas in a production facility where little or no export steam is produced. Most or all of the steam produced from the waste heat from the process is used in the steam-hydrocarbon reformer. Reformed gas is passed to a pressure swing adsorption system for H | 09-17-2009 |
20090232729 | Steam-Hydrocarbon Reforming Method with Limited Steam Export - A method for generating hydrogen and/or synthesis gas in a production facility where little or no export steam is produced. Most or all of the high pressure steam produced from the waste heat from the process is used in the steam-hydrocarbon reformer with little or no steam export. The method uses oxygen enhanced combustion which may involve oxygen lancing and/or oxygen-enrichment. Plant efficiencies using the method and prior art-type methods are compared. | 09-17-2009 |
20100310949 | Steam-Hydrocarbon Reforming with Reduced Carbon Dioxide Emissions - A process for producing a hydrogen-containing product gas with reduced carbon dioxide emissions compared to conventional hydrogen production processes. A hydrocarbon and steam are reformed in a reformer and the resulting reformate stream is shifted in one or more shift reactors. The shifted mixture is scrubbed to remove carbon dioxide to form a carbon dioxide-depleted stream. The carbon dioxide-depleted stream is separated to form a hydrogen-containing product gas and a by-product gas. A portion of the hydrogen containing product gas is used as a fuel in the reformer and a portion of the by-product gas is recycled back into the process. The process may optionally include reforming in a prereformer and/or an oxygen secondary reformer. | 12-09-2010 |
20130047665 | Process and Apparatus for Producing Hydrogen and Carbon Monoxide - Apparatus and process for producing a hydrogen-containing product stream and a carbon monoxide-containing product stream from a crude synthesis gas produced in a syngas production unit. Carbon dioxide is removed from the process gas by a non-cryogenic means and the hydrogen-containing product stream is separated from the process gas in a pressure swing adsorber. Residual gas from the pressure swing adsorber is passed to a cryogenic separation unit where the cryogenic separation unit separates the residual gas stream into the carbon monoxide-containing product stream, a hydrogen-enriched stream, a methane-enriched stream, and a carbon monoxide-containing intermediate stream by cryogenic fractionation. At least a portion of the hydrogen-enriched stream is recycled to the pressure swing adsorber. | 02-28-2013 |
20130097929 | Process for Producing Hydrogen - A process for producing a hydrogen-containing product gas with reduced carbon dioxide emissions compared to conventional hydrogen production processes. A hydrocarbon and steam are reformed in a reformer and the resulting reformate stream is shifted in at least two shift reactors. The shifted mixture is separated to form a CO | 04-25-2013 |
20130243686 | Hydrogen Production Process with Low CO2 Emissions - A hydrogen production process wherein steam and a hydrocarbon feed is reacted in a prereformer, the prereformed intermediate is further reacted in an oxygen-based reformer, the reformate is shifted and then separated by a pressure swing adsorber to form a H | 09-19-2013 |
Patent application number | Description | Published |
20090222714 | COLLAPSING MARGINS IN DOCUMENTS WITH COMPLEX CONTENT - Architecture that facilitates the calculation of the final margins and positions of all objects in one formatting pass, without the need to reformat an object in the margin neighborhood. Clearance objects, float objects, and empty objects are taken into account. The one-pass algorithm computes the positions of objects on the document due to collapsing margins, determines the sizes of the resulting collapsed margins, and correctly places empty objects, floats, and clearance objects in the document. Clearances due to objects that belong to the neighborhood are processed as well as clearances due to objects outside of the neighborhood. | 09-03-2009 |
20090222722 | OPTIMAL SIZES OF OBJECTS IN A DOCUMENT - Architecture of one or more algorithms for autofitting objects with non-trivial geometries in documents. The algorithms autofit rectangular objects (such as floaters), when the objects contain both left and right aligned objects, autofit tables, determine correct sizes of a parent object and its child object when the width of the parent object is unknown (referred to as an auto-width), and the width of the parent's child object is expressed in percentages of the parent object width. A two-pass algorithm determines the best (or optimal) sizes of margins, borders, and paddings of objects where any combination thereof can have fixed width, auto width, and/or percentage-expressed width. Additionally, the algorithms can recursively calculate the optimal widths of objects inside other objects, where the outer object width is undefined. The algorithms can process an unlimited number of nesting levels. | 09-03-2009 |
20130111333 | SCALING OBJECTS WHILE MAINTAINING OBJECT STRUCTURE | 05-02-2013 |